| pubmed-article:11966746 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11966746 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
| pubmed-article:11966746 | lifeskim:mentions | umls-concept:C0023779 | lld:lifeskim |
| pubmed-article:11966746 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
| pubmed-article:11966746 | lifeskim:mentions | umls-concept:C0039082 | lld:lifeskim |
| pubmed-article:11966746 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:11966746 | lifeskim:mentions | umls-concept:C0011155 | lld:lifeskim |
| pubmed-article:11966746 | lifeskim:mentions | umls-concept:C1979963 | lld:lifeskim |
| pubmed-article:11966746 | lifeskim:mentions | umls-concept:C0559956 | lld:lifeskim |
| pubmed-article:11966746 | lifeskim:mentions | umls-concept:C2003903 | lld:lifeskim |
| pubmed-article:11966746 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11966746 | pubmed:dateCreated | 2002-4-22 | lld:pubmed |
| pubmed-article:11966746 | pubmed:abstractText | Adult growth hormone deficiency (AGHD) is associated with an adverse lipid profile. The majority of previous studies of GH replacement have used supraphysiological doses and reported favourable changes in the lipid profile. Whether this beneficial effect is the result of pharmacological GH therapy, or occurs in response to low-dose GH replacement aimed at normalization of the serum IGF-I, has not been fully elucidated. | lld:pubmed |
| pubmed-article:11966746 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11966746 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11966746 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11966746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11966746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11966746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11966746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11966746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11966746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11966746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11966746 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11966746 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:11966746 | pubmed:issn | 0300-0664 | lld:pubmed |
| pubmed-article:11966746 | pubmed:author | pubmed-author:ShaletS MSM | lld:pubmed |
| pubmed-article:11966746 | pubmed:author | pubmed-author:MurrayR DRD | lld:pubmed |
| pubmed-article:11966746 | pubmed:author | pubmed-author:WieringaG EGE | lld:pubmed |
| pubmed-article:11966746 | pubmed:author | pubmed-author:LissettC ACA | lld:pubmed |
| pubmed-article:11966746 | pubmed:author | pubmed-author:SmethurstL... | lld:pubmed |
| pubmed-article:11966746 | pubmed:author | pubmed-author:DarzyK HKH | lld:pubmed |
| pubmed-article:11966746 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11966746 | pubmed:volume | 56 | lld:pubmed |
| pubmed-article:11966746 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11966746 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11966746 | pubmed:pagination | 525-32 | lld:pubmed |
| pubmed-article:11966746 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:meshHeading | pubmed-meshheading:11966746... | lld:pubmed |
| pubmed-article:11966746 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11966746 | pubmed:articleTitle | Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome. | lld:pubmed |
| pubmed-article:11966746 | pubmed:affiliation | Department of Endocrinology, The Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK. | lld:pubmed |
| pubmed-article:11966746 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11966746 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11966746 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
